secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monterey Innovation Acquisition Corp (—)
CIK:        0001860663
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001104659-23-030940
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Monterey Bio Acquisition rebrands as Monterey Innovation; appoints new CEO, CFO, and directors
--------------------------------------------------------------------------------

- Sanjeev Satyal resigned as CEO, William McKeever resigned as CFO and director on March 9, 2023.
- Murat Omur (Chardan Capital Markets) appointed CEO; Sean McGann (Chardan) appointed CFO.
- Three new directors added: Chris Coleman, Jory Des Jardins, Roderick Hardamon; Jonas Grossman named Executive Chairman.
- Company changed name from Monterey Bio Acquisition Corp. to Monterey Innovation Acquisition Corp., effective March 10, 2023.
- Acquisition strategy expanded to include broader disruptive technology targets, beyond biotech.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860663/000110465923030940/0001104659-23-030940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860663/000110465923030940/tm239085d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-030940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer